Cargando…
Quetiapine and novel PDE10A inhibitors potentiate the anti-BuChE activity of donepezil
The symptoms of Alzheimer’s disease (AD) do not include only memory loss and cognitive decline but also neuropsychiatric manifestation. These AD-related symptoms are usually treated with the aid of antipsychotics; however, their effects on cognition and safety remain unexplored. The present study de...
Autores principales: | Sikora, Joanna, Podsiedlik, Maria, Pietras, Tadeusz, Kosmalski, Marcin, Matłoka, Mikołaj, Moszczyński-Petkowski, Rafał, Wieczorek, Maciej, Markowicz-Piasecka, Magdalena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534323/ https://www.ncbi.nlm.nih.gov/pubmed/32938236 http://dx.doi.org/10.1080/14756366.2020.1818739 |
Ejemplares similares
-
The Influence of Selected Antipsychotic Drugs on Biochemical Aspects of Alzheimer’s Disease
por: Podsiedlik, Maria, et al.
Publicado: (2022) -
In Vitro Anti-AChE, Anti-BuChE, and Antioxidant Activity of 12 Extracts of Eleutherococcus Species
por: Załuski, Daniel, et al.
Publicado: (2016) -
Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation
por: Markowicz-Piasecka, Magdalena, et al.
Publicado: (2018) -
Tuning the activity of iminosugars: novel N-alkylated deoxynojirimycin derivatives as strong BuChE inhibitors
por: Ahuja-Casarín, Ana I., et al.
Publicado: (2020) -
Constituents and Selective BuChE Inhibitory Activity of the Essential Oil from Hypericum aciculare Kunth
por: Calva, James, et al.
Publicado: (2023)